The herd effects of infant PCV7/PCV13 sequential implementation on adult invasive pneumococcal disease, six years post implementation; a nationwide study in Israel (Q38876677)

From Wikidata

Jump to navigation Jump to search

scientific article published on 22 March 2017

Language	Label	Description	Also known as
English	The herd effects of infant PCV7/PCV13 sequential implementation on adult invasive pneumococcal disease, six years post implementation; a nationwide study in Israel	scientific article published on 22 March 2017

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

The herd effects of infant PCV7/PCV13 sequential implementation on adult invasive pneumococcal disease, six years post implementation; a nationwide study in Israel (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

0 references

Gili Regev-Yochay

1

object named as

Gili Regev-Yochay

0 references

object named as

Yasmin Maor

7

0 references

10

object named as

Ron Dagan

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Jacob Strahilevitz

3

object named as

Jacob Strahilevitz

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

8

object named as

Bibiana Chazan

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

4

object named as

Galia Rahav

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

author name string

Michal Katzir

2

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Talya Finn

5

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Dan Miron

6

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Yehudith Schindler

9

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

IAIPD group

11

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

language of work or name

0 references

publication date

22 March 2017

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

2449-2456

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Pneumococcal infection in adults: burden of disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Rapid reduction in invasive pneumococcal disease after introduction of PCV7 into the National Immunization Plan in Israel

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Early impact of PCV7/PCV13 sequential introduction to the national pediatric immunization plan, on adult invasive pneumococcal disease: A nationwide surveillance study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Impact of PCV7/PCV13 introduction on invasive pneumococcal disease (IPD) in young children: Comparison between meningitis and non-meningitis IPD.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Differential impact of pneumococcal conjugate vaccines on bacteremic pneumonia versus other invasive pneumococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Influence of Childhood Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Adults With Underlying Comorbidities in Calgary, Alberta (2000-2013).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Pneumococcal disease prevention among adults: Strategies for the use of pneumococcal vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Evaluating the impact of PCV-10 on invasive pneumococcal disease in Brazil: A time-series analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

The Czech Surveillance System for Invasive Pneumococcal Disease, 2008-2013: A Follow-Up Assessment and Sensitivity Estimation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programme

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Early impact of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine on IPD in Israeli children <5 years: an active prospective nationwide surveillance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Cost-Effectiveness of Vaccinating Immunocompetent ≥65 Year Olds with the 13-Valent Pneumococcal Conjugate Vaccine in England

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Pneumococcal pneumonia prevention among adults: is the herd effect of pneumococcal conjugate vaccination in children as good a way as the active immunization of the elderly?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Pneumococcal Disease Prevention Among Adults: Strategies for the Use of Pneumococcal Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Why the recent ACIP recommendations regarding conjugate pneumococcal vaccine in adults may be irrelevant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Is pneumonia really the old man's friend? Two-year prognosis after community-acquired pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.03.031

7 January 2021

Identifiers

10.1016/J.VACCINE.2017.03.031

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38876677&oldid=2232276845"